Changes in the vasculature of the cyclic ovary, especially during the growth of follicles and corpus lutea, are rapid and profound (Gospodarowicz and Thakral, 197 8; Kanzaki et al., 1981; Zeleznik et al., 1981; Koos and DeMaire, 1983) . At these stages, rapid neovascularization (angiogenesis) takes place in the wall of the developing follicles (Kanzaki et al., 1981; Zeleznik et al., 1981; Koos and DeMaire, 1983) ) and in the corpus luteum (Gospodarowicz and Thakral, 1978) . This increase in vascularization during follicular growth and luteinization may be dependent upon the production of angiogenic factors by the ovary. We observed that neovascularization is induced by the extract of nonluteal mouse ovaries and that high angiogenic activity is identified in the ovarian extract from mice injected with human chorionic gonadotropin(hCG) or pregnant mare serum gonadotropin (PMSG) (Sato et al., 1982) .
In the present study, the effect of follicle-stimulating hormone (FSH) on the angiogenic activity of mouse ovaries was examined and then ovarian angiogenic factors were partially purified from the extract of nonluteal ovaries of mice injected with FSH. Preparation of ovarian extracts Immature female mice (Jcl: ICR strain, 4 weeks old, 20-22 g body weight) were injected. with 1 i.u. of FSH dissolved in 0.3 ml of physiological saline. The injections were repeated after 24 hrs. The ovaries were excised 24 hrs after the second injection of FSH. Ovaries from untreated mice were used as the control. The ovaries were homogenized in 0.5 M ammonium carbonate with an ultrasonicator.
The homogenates were centrifuged at 54,000 g for 1 hr. The supernatant was collected, dialyzed against three changes of one liter of distilled water, lyophilized and tested for angiogenic activity. 
Results
The control Elvax 40 films were innocuous although tissue reaction did occur, characterized by the formation of several layers of connective tissue cells surrounding the film (Fig. 4-A) . Since neovascularization may occur in association with inflammation, the tissue were examined for signs of in- the tissues were examined under a stereolight microscope (4.6%) as in histological examination (5.7%). Neovascularization without inflammation was observed with 0-3% of the implanted control films in this series of experiments. Implanted films containing ovarian extract showed marked neovascularization, characterized by extensive capillary outgrowths extending into the surrounding tissue ( Fig.3  and 4-B) .
Angiogenic activities of the extracts prepared from ovaries of FSH-treated mice are shown in Figs 1 and 2 . The neovascularizing activity increased with the dose and duration of theinplantation.
On the the 15th day of the implantation, 75% of fraction soluble at 20% saturation and precipitated out at 50% saturation showed the highest angiogenic activities (Table 1) .
Discussion
The present findings that ovarian extract from untreated mice showed angiogenic activity suggests that an angiogenic factor is present in the immature ovary. The greater potency of ovarian extracts prepared from FSH-treated mice indicates that the angiogenic activity was enhanced by FSH administration as well as PMSG or hCG injection (Sato et al., 1982) . Although the mechanism of neovascularization is not known, it is possible that the ovarian angiogenic factor is chemoattractant for macrophages which possess potent angiogenic activities (Polveriri et al., 1977) . However it should be pointed out that angiogenesis induced by ovarian extracts is not a consequence of a non-specific inflammatory reaction.
Inflammation is the most potent inducer of angiogenesis and is a troublesome source of artifactual capillary proliferation (Jakob et al., 1977; Folkman, 1982) . To exclude inflammation and to score as a true noninflammatory angiogenic response to the extracts, there should be no edema or leukocytic infiltration about the implants. Neovascularization induced by certain compounds such as bovine serum albumin (BSA) is characterized by an inflammatory reaction associated with infiltration of leukocytes and macrophages into the subcutaneous tissue (Sato et al., 1982) . In the present study in- Extracts were prepared from ovaries of FSH-treated mice. a, P<0.05, compared with the control value. Fraction; A, precipitated at 20% saturation; B, precipitated at 50% saturation; C, residual soluble fraction at 50% saturation.
incidence of non-specific inflammation with control films was minimized to 5%. FSH used in the present study can induce follicular growth since 2 i.u. of this hormone promotes development of antral follicles in mice.
The ovarian sections showed a marked increase in the number of antral follicles each with a single coalesced cavity (stage V and VI) according to the criteria of Greenwald (1974) . Hence, the follicle stimulating activity and the angiogenic activity may be related.
The angiogenic factor obtained from porcine ovaries has been reported to be a cationic polypeptide produced by theca cells (Makris et al., 1984) . It is sensitive to boiling and stable to reducing agents. The active factor is soluble in 40% saturated ammonium sulfate solution and precipitated at 60% saturation (Makris et al., 1984) . In contrast, the factor mentioned here is stable to heating. The conditioning medium of rat granulosa cells stimulates growth and elongation of endothelial cells and tubule formation in culture (Koos, 1986) . The active factor is a high molecular weight, heat-stable protein which is destroyed completely by trypsin and acid treatment (Koos, 1986) .
The ovarian proteinous angiogenic factor (OPAF) may be related to the basic fibroblast growth factor (FGF) of corpus luteum (Gospodarowicz et al., 1985) , or the endothelial cell growth factor (ECGF) identified in human platelets (King and Buchwald, 1984) . Basic FGF has been isolated from corpus luteum (Gospodarowicz et al., 1985) . FGF consists of a single chain polypeptide with an estimated Mr of 16 kD. ECGF is heat-labile protein with an apparent Mr of 65 and 135 kD (King and Buchwald, 1984) . They stimulate endothelial cell growth and are less active on fibroblasts. An angiogenic factor has been isolated from an established human adenocarcinoma cell line (HT-29) and named angiogenin . Angiogenin is a single-chain protein consisting of 123 amino acid residues Kurachi et al., 1985) . The physico-chemical nature of ovarian angiogenic factor described here is now under investigation with spectial reference to the possibility that the factor is one of these substances with angiogenic activities.
